Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 276

1.

Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation.

Punglia RS, Cronin AM, Uno H, Stout NK, Ozanne EM, Greenberg CC, Frank ES, Schrag D.

JAMA Oncol. 2016 Jul 21. doi: 10.1001/jamaoncol.2016.2164. [Epub ahead of print]

PMID:
27442038
2.

Effects of state-level medicaid policies and patient characteristics on time to breast cancer surgery among medicaid beneficiaries.

Halpern MT, Schrag D.

Breast Cancer Res Treat. 2016 Aug;158(3):573-81. doi: 10.1007/s10549-016-3879-8. Epub 2016 Jul 15.

PMID:
27422241
3.

An ED pilot intervention to facilitate outpatient acute care for cancer patients.

Brooks GA, Chen EJ, Murakami MA, Giannakis M, Baugh CW, Schrag D.

Am J Emerg Med. 2016 Jun 24. pii: S0735-6757(16)30294-7. doi: 10.1016/j.ajem.2016.06.076. [Epub ahead of print]

PMID:
27412915
4.

Living in a material world: tumor-treating fields at the top of the charts.

Schiff D, Schrag D.

Neuro Oncol. 2016 Aug;18(8):1033-4. doi: 10.1093/neuonc/now138. No abstract available.

PMID:
27382117
5.

Beyond Composite Endpoints Analysis: Semicompeting Risks as an Underutilized Framework for Cancer Research.

Jazić I, Schrag D, Sargent DJ, Haneuse S.

J Natl Cancer Inst. 2016 Jul 5;108(12). pii: djw154. doi: 10.1093/jnci/djw154. Print 2016 Dec.

PMID:
27381741
6.

Racial/Ethnic and Socioeconomic Differences in Colorectal and Breast Cancer Treatment Quality: The Role of Physician-level Variations in Care.

Popescu I, Schrag D, Ang A, Wong M.

Med Care. 2016 Aug;54(8):780-8. doi: 10.1097/MLR.0000000000000561.

PMID:
27326547
7.

Multimodal Rectal Cancer Treatment: In Some Cases, Less May Be More.

Garcia-Aguilar J, Glynne-Jones R, Schrag D.

Am Soc Clin Oncol Educ Book. 2016;35:92-102. doi: 10.14694/EDBK_159221.

8.

Reimbursing Wisely? CMS's Trial of Medicare Part B Drug Payment Reform.

Schrag D.

N Engl J Med. 2016 Jun 2;374(22):2101-5. doi: 10.1056/NEJMp1603735. No abstract available.

PMID:
27248616
9.

Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received.

Schnipper LE, Davidson NE, Wollins DS, Blayney DW, Dicker AP, Ganz PA, Hoverman JR, Langdon R, Lyman GH, Meropol NJ, Mulvey T, Newcomer L, Peppercorn J, Polite B, Raghavan D, Rossi G, Saltz L, Schrag D, Smith TJ, Yu PP, Hudis CA, Vose JM, Schilsky RL.

J Clin Oncol. 2016 Aug 20;34(24):2925-34. doi: 10.1200/JCO.2016.68.2518. Epub 2016 May 31. No abstract available.

PMID:
27247218
10.

Optimizing Treatment for Locally Advanced Pancreas Cancer: Progress but No Precision.

Schrag D.

JAMA. 2016 May 3;315(17):1837-8. doi: 10.1001/jama.2016.4284. No abstract available.

PMID:
27139054
11.

Use of a novel statistical technique to examine the delivery of breast cancer follow-up care by different types of oncology providers.

Neuman HB, Rathouz PJ, Winslow E, Weiss JM, LoConte NK, Lin CP, Wurm M, Smith MA, Schrag D, Greenberg CC.

J Eval Clin Pract. 2016 Mar 17. doi: 10.1111/jep.12529. [Epub ahead of print]

PMID:
26991311
12.

Association of Financial Strain With Symptom Burden and Quality of Life for Patients With Lung or Colorectal Cancer.

Lathan CS, Cronin A, Tucker-Seeley R, Zafar SY, Ayanian JZ, Schrag D.

J Clin Oncol. 2016 May 20;34(15):1732-40. doi: 10.1200/JCO.2015.63.2232. Epub 2016 Feb 29.

PMID:
26926678
13.

Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Bennett AV, Dueck AC, Mitchell SA, Mendoza TR, Reeve BB, Atkinson TM, Castro KM, Denicoff A, Rogak LJ, Harness JK, Bearden JD, Bryant D, Siegel RD, Schrag D, Basch E; National Cancer Institute PRO-CTCAE Study Group.

Health Qual Life Outcomes. 2016 Feb 19;14:24. doi: 10.1186/s12955-016-0426-6.

14.

Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the community.

Hassett MJ, Jiang W, Habel LA, Nekhlyudov L, Achacoso N, Acton L, Schnitt SJ, Schrag D, Punglia RS.

Breast Cancer Res Treat. 2016 Feb;155(3):541-9. doi: 10.1007/s10549-016-3692-4. Epub 2016 Feb 3.

PMID:
26843057
15.

Dartmouth Atlas Area-Level Estimates of End-of-Life Expenditures: How Well Do They Reflect Expenditures for Prospectively Identified Advanced Lung Cancer Patients?

Keating NL, Landrum MB, Huskamp HA, Kouri EM, Prigerson HG, Schrag D, Maciejewski PK, Hornbrook MC, Haggstrom DA.

Health Serv Res. 2016 Aug;51(4):1584-94. doi: 10.1111/1475-6773.12440. Epub 2016 Jan 22.

PMID:
26799913
16.

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.

Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, Rogak L, Bennett AV, Dueck AC, Atkinson TM, Chou JF, Dulko D, Sit L, Barz A, Novotny P, Fruscione M, Sloan JA, Schrag D.

J Clin Oncol. 2016 Feb 20;34(6):557-65. doi: 10.1200/JCO.2015.63.0830. Epub 2015 Dec 7. Erratum in: J Clin Oncol. 2016 Jun 20;34(18):2198.

PMID:
26644527
17.

The utility of cost discussions between patients with cancer and oncologists.

Zafar SY, Chino F, Ubel PA, Rushing C, Samsa G, Altomare I, Nicolla J, Schrag D, Tulsky JA, Abernethy AP, Peppercorn JM.

Am J Manag Care. 2015 Sep;21(9):607-15.

18.

Intensity of Medical Interventions between Diagnosis and Death in Patients with Advanced Lung and Colorectal Cancer: A CanCORS Analysis.

Brooks GA, Cronin AM, Uno H, Schrag D, Keating NL, Mack JW.

J Palliat Med. 2016 Jan;19(1):42-50. doi: 10.1089/jpm.2015.0190. Epub 2015 Nov 24.

PMID:
26600474
19.

Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial.

Basch E, Wood WA, Schrag D, Sima CS, Shaw M, Rogak LJ, Kris MG, Shouery M, Bennett A, Atkinson T, Pietanza MC.

Clin Trials. 2016 Jun;13(3):331-7. doi: 10.1177/1740774515615540. Epub 2015 Nov 4.

PMID:
26542025
20.

Variation in breast cancer care quality in New York and California based on race/ethnicity and Medicaid enrollment.

Hassett MJ, Schymura MJ, Chen K, Boscoe FP, Gesten FC, Schrag D.

Cancer. 2016 Feb 1;122(3):420-31. doi: 10.1002/cncr.29777. Epub 2015 Nov 4.

PMID:
26536043
Items per page

Supplemental Content

Loading ...
Write to the Help Desk